Oncolytics Biotech
ONCY
NASDAQ
IPO2001
about ONCY
Oncolytics Biotech develops innovative cancer treatments, including a proprietary interferon alfa-based therapeutic platform designed to target and treat cancers while sparing healthy cells.
| type | open | high | low |
market cap |
volume |
|---|---|---|---|---|---|
| stock | $0.98 | $1.01 | $0.95 | $104.10M | 562.12K |